01—Abstract
Summary
Summary of the 8-K filed June 3, 2005. Cited figures are marked; the original filing is the authoritative source.
CIENA CORP (CIEN) filed an 8-K on June 3, 2005, reporting a material amendment to its stockholder rights agreement.
Specifically, Amendment No. 4, entered into on June 2, 2005, modifies the definition of an "Acquiring Person." This amendment provides an exemption for FMR Corp. (a significant institutional stockholder) and its affiliates from being classified as an "Acquiring Person," provided certain conditions are met. The key condition for FMR Corp. is that its beneficial ownership of Ciena's common stock must remain below 20%a.
Additionally, FMR Corp. must report its ownership on either a Schedule 13G or 13D, and if a Schedule 13D is filed, it must not express an intention to influence or change Ciena's control, nor participate in any transaction with such a purpose. This filing is significant as it directly addresses the relationship with a major shareholder and potentially alters the company's poison pill defense strategy in relation to FMR Corp.
02—Key points
Key Highlights
- Ciena Corporation amended its Stockholder Rights Agreement (poison pill) on June 2, 2005.
- The amendment, designated as Amendment No. 4, modifies the definition of an 'Acquiring Person'.
- FMR Corp. and its affiliates are exempted from being classified as an 'Acquiring Person' under specific conditions.
- The exemption for FMR Corp. is contingent on its beneficial ownership of Ciena's common stock staying below 20%.
- A further condition requires FMR Corp. to report its ownership on Schedule 13G or 13D.
- If FMR Corp. files a Schedule 13D, it must not indicate an intent to change or influence control of Ciena.
- This amendment appears to address potential concerns or arrangements with a significant institutional stockholder, FMR Corp.
03—Questions
Frequently Asked Questions
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to announce a material amendment to Ciena Corporation's Stockholder Rights Agreement. This amendment modifies the definition of an 'Acquiring Person' to provide an exemption for FMR Corp., a significant institutional stockholder, under specific ownership and control conditions.
Who is FMR Corp. and why is an exemption being granted to them?
FMR Corp. is identified as one of Ciena's institutional stockholders. The exemption is being granted to FMR Corp. and its affiliates as long as they maintain beneficial ownership of less than 20% of Ciena's outstanding common stock and do not express an intent to change or influence the control of Ciena, as detailed in their SEC filings.
How does this amendment affect Ciena's 'poison pill' defense?
This amendment effectively carves out FMR Corp. from the standard 'poison pill' triggered by becoming an 'Acquiring Person,' provided FMR Corp. adheres to the specified ownership thresholds and intentions. It suggests a tailored approach to managing relationships with significant shareholders while maintaining the general defense mechanism for other potential acquirers.
What are the key conditions FMR Corp. must meet to maintain this exemption?
FMR Corp. must ensure its beneficial ownership of Ciena's common stock remains below 20%. Additionally, it must report its ownership status on a Schedule 13G or 13D, and if a Schedule 13D is filed, it must explicitly state no present intention to change or influence Ciena's control.
04—Continue